Nihon Kohden (OTCMKTS:NHNKY) Reaches New 12-Month Low – What’s Next?

Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) shares hit a new 52-week low during trading on Monday . The company traded as low as $8.1225 and last traded at $8.1225, with a volume of 1158 shares changing hands. The stock had previously closed at $8.48.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy”.

Get Nihon Kohden alerts:

Read Our Latest Analysis on Nihon Kohden

Nihon Kohden Stock Up 1.0%

The stock has a 50-day simple moving average of $9.22 and a 200-day simple moving average of $10.16. The firm has a market capitalization of $1.46 billion, a PE ratio of 14.46 and a beta of 0.39.

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last released its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%.The business had revenue of $453.10 million during the quarter, compared to the consensus estimate of $414.40 million. Equities analysts forecast that Nihon Kohden Corporation will post 0.61 earnings per share for the current fiscal year.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

Read More

• Five stocks we like better than Nihon Kohden
• Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
• CoreWeave Insider Sales Look Big, But Should Investors Worry?
• Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
• Meta and Cloud Computing: Real Potential, or a Shot in the Dark?

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.